摘要
目的:通过分析我国有关干细胞科技论文被国际权威检索工具PubMed收录情况,评价我国干细胞领域的发展历程及应用前景。方法:应用文献计量学和数理统计方法对PubMed收录我国干细胞领域科技论文进行统计分析。结果:PubMed一共收录我国干细胞领域科技论文8039篇,其中中文文献2021篇,外文文献6018篇;北京、上海、广东、台湾四个地区发文量领先于其他地区;排名前三的发文机构为中山大学、上海交通大学和中国医学科学院北京协和医院;国际期刊分布中Biochem Biophys Res Commun、Biomaterials、PLoS One位列前三甲;国内期刊分布中中国实验血液学杂志、中国修复重建外科杂志、中华医学杂志位列前三甲;主题分布中高频主题词有间充质干细胞、骨髓细胞、造血干细胞,等;干细胞治疗疾病常见的有白血病、心肌梗死、肝肿瘤,等。结论:我国干细胞起步于1986年,于2000年后快速发展,发文量成几何倍数增长,干细胞的发展将对我国传统医疗手段和医疗观念造成一场重大的革命。
Objective： To evaluate the development and application perspective of stem cells through bibliometric by analyzing the scientific papers on stem cells research embodied by PubMed database in China. Methods： Each biliometrics index of scientific papaers was analyzed with literature metrology. Results： 8039 articles were embodied by PubMed, with 2021 Chinese articles and 6018 foreign articles. The total amount of articles from Beijing, Shanghai, Guangdong, Taiwan ranked top than other areas. The top three institutions were Sun Yat-Sen University, Shanghai Jiao Tong University and Chinese Academy of Medical Sciences Beijing Union Medical College. The top three foreign publications were Biochem Biophys Res Commun, Biomaterials, PLoS One. The top three Chinese publications were Journal of Experimental Hematology, Chinese Journal of Reparative and Reconstructive Surgery, and National Medical Journal of China. The main subject headings were mesenchymal stem cells, bone marrow cells, hematopoietic stem cells, et al. The main disease treatment of stem cells was leukemia, myocardial infarction, liver neoplasms, et al. Conclusion： Stem cells research started in 1986, and developed rapidly atter 2000. The development of stem cells was great promotion for traditional medical treatment and medical ideas.
出处
《现代生物医学进展》
CAS
2014年第15期2956-2961,共6页
Progress in Modern Biomedicine
基金
南京军区福州总医院院基金(201246)
